Chadv13-202 - CME Group

Testing for CME Europe
- - To
  - Clearing Member Firms
- - From
  - CME Clearing
- - #
  - 13-202
- - Notice Date
  - 30 April 2013
- - Effective Date
  - 30 April 2013
- CME Clearing Europe has published Clearing Notice 13-35, detailing the testing process in the New Release environment for the CME Europe exchange.
  
  The main CME Clearing Europe page for its clearing advisories is located at:
  
  http://www.cmeclearingeurope.com/clearing/clearing-member-notices.html
  
  Clearing Notice 13-35 is located at:
  
  http://www.cmeclearingeurope.com/clearing/files/cmece-margin-change-advisory-13-35.pdf
  
  Appendix 1 to Clearing Notice 13-35 is located at:
  
  http://www.cmeclearingeurope.com/clearing/files/appendix-1-to-13-35.pdf
  
  The appendix contains detailed specifications for each CME Europe product needed for configuring the product in bookkeeping systems.
  
  For more information please contact CME Clearing Europe at:
  Group Helpdesk: +44 20 3379 3131
  
  Group Email: ClearingSupport_London@cmeclearingeurope.com
  
  13-202
  
  Click here for a printer friendly version

Send Us Feedback

Who We Are

CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.